Chemours acquisitions, on the record

Word for word“In June 2023, the Company entered into a definitive agreement with PureTech Scientific Inc. to sell the Company's Glycolic Acid business, included in the Company's Other Segment, for cash consideration of approximately $ 137 (the “Glycolic Acid Transaction”).” 10-K for 2023

Word for word“On July 26, 2021, the Company entered into a definitive agreement with Manchester Acquisition Sub LLC, a Delaware limited liability company and a subsidiary of Draslovka Holding a.s., to sell the Mining Solutions business of its Chemical Solutions segment for cash consideration of approximately $ 520 (the “Mining Solutions Transaction”).” 10-K for 2023

Word for word“Upon completion of the Beaumont Transaction and the Pascagoula Transaction, the Company recorded a net pre-tax gain of $ 5 and $ 18 , respectively, in other income, net in the consolidated statements of operations during the year ended December 31, 2022.” 10-K for 2023

Word for word“Upon completion of the Beaumont Transaction and the Pascagoula Transaction, the Company recorded a net pre-tax gain of $ 5 and $ 18 , respectively, in other income, net in the consolidated statements of operations during the year ended December 31, 2022.” 10-K for 2023

Word for word“Additionally, in January 2026, we entered into four separate Real Estate Sale and Purchase Agreements with four entities affiliated with each other (collectively, the "Purchase Agreements"), to sell ten parcels of land in Kuan Yin, Taiwan, for a total purchase price of approximately $360 million.” 10-K for 2025